Polyetherimide- and folic acid-modified Fe<sub>3</sub> O<sub>4</sub> nanospheres for enhanced magnetic hyperthermia performance.

Wang, Qinganzi; Cheng, Yuemei; Wang, Wenhua; Tang, Xiaolin; Yang, Yongxiu · J Biomed Mater Res B Appl Biomater · 2023

basic_science · Level V

Where this comes from

Abstract

Recent studies have highlighted the development prospects of magnetic hyperthermia in cancer therapy. A few studies on the application of Fe<sub>3</sub> O<sub>4</sub> nanospheres for the magnetic hyperthermia of gynecological malignancies have achieved certain efficacy, but there was no visible progress currently. In this work, Fe<sub>3</sub> O<sub>4</sub> nanospheres modified with polyetherimide (PEI) and folic acid (FA) were synthesized using a hydrothermal method for possible utility in biocompatible and active tumor-targeting magnetic induction hyperthermia. The PEI- and FA-coated Fe<sub>3</sub> O<sub>4</sub> nanospheres showed high crystallinity, well-dispersed spherical structures and ideal M<sub>s</sub> value. As a result, the designed Fe<sub>3</sub> O<sub>4</sub> @ PEI@FA nanospheres achieved higher specific absorption rate (SAR) values at 360 kHz and 308 Oe, as well as excellent biocompatibility in Hela, SKOV3, HEC-1-A and NIH3T3 cells. These nanospheres can be used as an optimal heating agent for the magnetic hyperthermia treatment of gynecological cancers.

Medical subject headings